Ningbo Yinzhou People's Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Ningbo City China (1949)

Organization Overview

First Clinical Trial
2020
NCT04077866
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ningbo Municipal Yinzhou District No.2 Hospital | Ningbo Yinzhou People's Hospital | Ningbo Yinzhou People's Hospital，Ningbo, China

Active Ingredients

Drugs in Phase 4 Trials (2)

resminostat (1 trial)

rituximab (rituxan) (1 trial)

Drugs in Phase 2 Trials (3)

almonertinib (1 trial)

b7-h3 car-t (1 trial)

temozolomide (temodar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioblastoma (Phase 2)

Glomerulonephritis, IGA (Phase 4)

Kidney Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5